Clinical Trial Update: Oxfendazole in Mild Parenchymal Brain Cysticercosis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 2/3 study evaluating oxfendazole for mild parenchymal brain cysticercosis, which is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cysticercosis

Drugs mentioned

• Oxfendazole (oxfendazole)

Snippet

Sponsor: Universidad Peruana Cayetano Heredia | Conditions: Brain Cysticercosis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING